This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.
Device | N16837S013 |
Classification Name | None |
Applicant | |
PMA | N16837 |
Supplement | S013 |
Supplement Number | Date | Supplement Type |
---|---|---|
N16837 | Original Filing | |
S029 | 2022-12-30 | 30-day Notice |
S028 | 2022-09-16 | 30-day Notice |
S027 | ||
S026 | 2020-04-07 | 30-day Notice |
S025 | 2018-06-15 | 30-day Notice |
S024 | 2017-12-29 | 30-day Notice |
S023 | 2017-12-19 | 30-day Notice |
S022 | 2017-08-16 | 30-day Notice |
S021 | 2015-09-11 | Real-time Process |
S020 | 2015-04-01 | Special (immediate Track) |
S019 | 2015-03-06 | Real-time Process |
S018 | 2014-09-04 | 30-day Notice |
S017 | 2014-07-30 | 30-day Notice |
S016 | ||
S015 | 2014-07-07 | Special (immediate Track) |
S014 | 2014-06-11 | Real-time Process |
S013 | ||
S012 | 2014-02-27 | 30-day Notice |
S011 | 2013-04-26 | Normal 180 Day Track No User Fee |
S010 | 2012-09-24 | 135 Review Track For 30-day Notice |
S009 | 2011-12-28 | 135 Review Track For 30-day Notice |
S008 | 2011-09-20 | 135 Review Track For 30-day Notice |
S007 | 2009-06-22 | 30-day Notice |
S006 | 2008-08-11 | 135 Review Track For 30-day Notice |
S005 | 2006-11-03 | Real-time Process |
S004 | 2006-02-01 | 30-day Notice |
S003 | 1999-07-29 | Normal 180 Day Track |
S002 | ||
S001 | 1979-06-29 |
Device ID | PMA | Supp |
---|---|---|
00316837000367 | N16837 | 000 |
00316837000190 | N16837 | 015 |
00316837000206 | N16837 | 015 |
00316837000213 | N16837 | 015 |
00316837000220 | N16837 | 015 |
00316837000237 | N16837 | 015 |
00316837000244 | N16837 | 015 |
00316837000251 | N16837 | 015 |
00316837000268 | N16837 | 015 |
00316837000275 | N16837 | 015 |
00316837000282 | N16837 | 015 |
00316837000299 | N16837 | 015 |
00316837000305 | N16837 | 015 |
00316837000312 | N16837 | 015 |
00316837000329 | N16837 | 015 |
00316837000336 | N16837 | 015 |
00316837000343 | N16837 | 015 |
00316837000350 | N16837 | 015 |